Picture of OptiNose logo

OPTN — OptiNose News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousSmall CapNeutral

OptiNose Inc expected to post a loss of 9 cents a share - Earnings Preview

* OptiNose Inc  OPTN.OQ   OPTN.O  is expected to show a fall
in
quarterly revenue when it reports  results on March 7 for the
period ending December 31 2023
    * The Yardley Pennsylvania-based  company is expected to
report a
7.8% decrease in revenue to $19.23 million from $20.86 million a
year ago, according to the mean estimate from 3 analysts, based
on LSEG data.
    * ​LSEG's mean analyst estimate for OptiNose Inc is for a
loss
of 9 cents per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 3 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for OptiNose
Inc is
$3.00​, above​ its last closing price of $1.78. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  LSEG IBES  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  ESTIMATE             MET,    SE %
               E®                               MISSED  
 Sep. 30 2023  -0.09       -0.09      -0.08     Beat    15.2
 Jun. 30 2023  -0.11       -0.11      0.02      Beat    118.4
 Mar. 31 2023  -0.14       -0.14      -0.17     Missed  -22​
 Dec. 31 2022  -0.17       -0.17      -0.17     Met     2.7
 ​​Sep.        -0.17       -0.18      -0.18     Met     2.7
 30 2022                                                
 Jun. 30 2022  -0.24       -0.24      -0.23     Beat    4.2​
 Mar. 31 2022  -0.27       -0.27      -0.31     Missed  -14.8
 Dec. 31 2021  -0.24       -0.26      -0.23     Beat    11.5
 This summary was machine generated March 1 at 13:41 GMT.  All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)

Recent news on OptiNose

See all news